Economy

Russia to supply 17 more countries with COVID-19 drug Avifavir

MOSCOW (Reuters) – Russia’s sovereign wealth fund and its partner Chemrar will supply the COVID-19 drug Avifavir to 17 additional countries, the fund said in a statement on Thursday.

Avifavir gained approval from the Russian health ministry in May and is based on favipiravir, which was developed in Japan and is widely used there as the basis for viral treatments.

Clinical trials in Japan and Russia have confirmed those drugs’ efficacy, the Russian Direct Investment Fund (RDIF) said in a statement.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s